Policy monitoring indexes targeting non-communicable diseases: protocol for a scoping review Authors: Helga Birgit Bjørnarå, Gerd Monika Flodgren, Arnfinn Helleve Published: 2026 ABSTRACT Abstract AbstractIntroductionCost-effective and feasible policy actions to prevent non-communicable diseases (NCDs) are identified, for example, WHO’s Best buys. Monitoring implementation of policy action can be a key indicator of progress in NCD prevention. Several policy monitoring indices have been developed to assess policies targeting NCDs. The objective of this scoping review is to map and synthesise scientific publications and relevant grey literature reporting on the design, characteristics and use of such indexes.Methods and analysisThe scoping review will follow Johanna Briggs Institute guidance and reporting will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping reviews. We will search eight databases (MEDLINE, Embase, Cochrane CENTRAL, Global Health, PsycINFO, Web of Science Core Collection, Scopus and FRANCIS) from 1 January 2013 onwards for eligible observational, quasi-experimental and mixed-methods studies in any language and reference lists of included studies and relevant reviews. Criteria for studies to be included are as follows: Population—any composite index designed to monitor the implementation of NCD relevant policies; Concept—monitoring, that is, the systematic collection, analysis and use of data targeting the implementation of policies aimed at reducing the prevalence of major NCDs and/or related behavioural risk factors; Context—national and/or supranational government-initiated policies implemented within the WHO European region. Conceptual-only papers, commentaries, conference abstracts, editorials and letters will be excluded. Screening and data extraction will be done in duplicate. Results will be synthesised narratively using descriptive statistics and visuals.Ethics and disseminationEthical approval is not required because the review does not involve primary data collection or direct interaction with human participants. The review is part of the Joint Action PreventNCD project, co-funded by the European Commission and involving 25 European countries. It will contribute to the project’s objectives of advancing monitoring systems for NCDs and behavioural risk factors. We plan to disseminate findings at international conferences and to publish the full review in an international peer-reviewed journal.Keywords: Health policy, PUBLIC HEALTH, Chronic Disease STRENGTHS AND LIMITATIONS OF THIS STUDY A key strength of this study is its alignment with established standards for conducting and reporting scoping reviews, alongside the use of recognised frameworks for data extraction and comprehensive and iterative literature searches. A key strength of this study is its alignment with established standards for conducting and reporting scoping reviews, alongside the use of recognised frameworks for data extraction and comprehensive and iterative literature searches. Another strength is that the study forms part of the multinational Joint Action PreventNCD initiative, which brings together researchers and stakeholders from numerous European countries, and this collaborative structure enhances the relevance, applicability and potential impact of the findings. Another strength is that the study forms part of the multinational Joint Action PreventNCD initiative, which brings together researchers and stakeholders from numerous European countries, and this collaborative structure enhances the relevance, applicability and potential impact of the findings. Potential biases will be minimised through duplicate screening and data extraction conducted independently by multiple reviewers. Potential biases will be minimised through duplicate screening and data extraction conducted independently by multiple reviewers. A limitation of the study is that it will not include a formal quality assessment of the included studies, which is consistent with standard scoping review methodology, but restricts conclusions about the robustness of the underlying evidence. A limitation of the study is that it will not include a formal quality assessment of the included studies, which is consistent with standard scoping review methodology, but restricts conclusions about the robustness of the underlying evidence. Introduction Non-communicable diseases and prevention initiatives Non-communicable diseases (NCDs) are the leading cause of death globally and account for more than two thirds of the total disease burden in Europe.1 Most NCDs are preventable through modifying key behavioural risk factors, including tobacco use, harmful alcohol consumption, unhealthy diets and physical inactivity.2 Cost-effective and feasible measures to address these risks, commonly referred to as the WHO ‘Best buys’,3 have been clearly identified. In 2015 all United Nations member states committed to reducing premature NCD mortality by one-third by 2030, as part of the Sustainable Development Goals (SDGs).4 Complementary to the WHO ‘Best buys’ both the ‘Healthier Together–EU NCD Initiative’5 and ‘Europe’s Beating Cancer Plan’6 provide support to European Union (EU) Member States in identifying and implementing evidence-based policies and actions aimed at reducing the burden of major NCDs and improving population health and well-being. Policy monitoring and complex policy indexes Monitoring systems serve several critical functions, including evaluating government policies, assessing developments in other countries and informing the ongoing refinement of national policy. Such systems help identify significant implementation gaps and highlight which actions should be prioritised.7 One approach to assessing implemented NCD or risk factor policies is to develop indicators that capture a wide range of policy actions and then combine these indicators into a composite index.8 Composite indexes have gained prominence as tools for synthesising information and offering an overview of policy landscapes across diverse domains. Moreover, a composite index may be easier to interpret than more abstract concepts, such as well-being or sustainability, because it offers both simplification and quantification.9 In other words, composite indexes provide a numeric expression of the degree of compliance with selected policy dimensions, often resulting in producing a rank-ordering of relevant measures.10 This approach captures essential information on countries’ performance in specific outcome areas, which then can inform targeted policy interventions and support the monitoring of trends over time. Developing a composite index is a delicate process, often challenged by limitations in data availability, the selection of appropriate indicators and differences in how those indicators are aggregated, weighted and compared.11 Indexes based on survey data are particularly vulnerable to bias arising from varying interpretations of survey questions, inconsistent reporting practices across countries and incomplete data sets. Another concern is the tension between the need for simplicity and the inherent complexity of policy; treating policies of different strength or effectiveness with equal weights may obscure important differences in their impact or comprehensiveness. In addition, aggregated measures may fail to capture not accurately reflect the nuanced policy contexts of individual nations12 or adequately reflect important historical and contextual factors.13 Global frameworks and alignment A key tool proposed for policy monitoring and evaluation is benchmarking, which involves the use of evidence-based, ambitious indicators for reference, rather than currently implemented best practice, when comparing progress on policy design and implementation within and across countries.14 Tracking national performance using a core set of indicators enables global benchmarking of progress on NCDs and highlights areas requiring greater policy prioritisation. Since 2015, WHO has published the NCD Progress Monitor every 2 years, drawing on data from the NCD Country Capacity Survey.15 In the NCD Progress Monitor, a modified set of eleven indicators are applied to assess compliance with the recommended ‘Best buys’ policies classifying countries as fully, partially or non-implementing these measures.16 Despite this, widespread adoption and implementation remain limited, and policy efforts are often fragmented.17 Moreover, the variability in the enforcement and practical application of policies across countries may create a disconnect between formal legal frameworks and their real-world application.12 Between 2015 and 2020 implementation of several policies declined, with the lowest levels observed for measures targeting alcohol, tobacco and unhealthy foods. Although there has been an overall upward trend, total NCD policy implementation remained below 50% in 2020.13 More recent reporting indicates progress since 2022 on selected NCD-indicators in more than 100 countries, yet momentum has slowed in several domains, including risk factor surveillance.16 At the same time, obesity and diabetes continue to increase and premature deaths from NCDs are rising globally.16 Taken together, progress is uneven and substantial challenges remain if the 2030 SDGs are to be reached. Current research on policy monitoring indexes targeting NCDs or NCD behavioural risk factors Several policy monitoring indexes have been developed to assess the implementation of NCD-related policies and associated risk factor control. For example, Allen et al13 produced cross-sectional NCD policy implementation scores for all 194 WHO Member States and examined changes over time using data from the WHO progress monitor reports for 2015, 2017 and 2020. Building on this approach, but narrowing its scope,13 Forray and Borzan12 applied a similar methodology to focus exclusively on the implementation of dietary strategies. In the area of physical activity, Woods et al7 developed the ‘Physical Activity Environment Policy Index’, a framework designed to evaluate government policies and actions aimed at creating supporting environments for physical activity. A comparable approach has been taken in the food domain: Swinburn et al18 proposed a monitoring framework to assess government actions to promote healthy food environments. For alcohol policy, Casswell et al19 created an index suitable for benchmarking alcohol policy across four domains (availability, pricing policy, alcohol marketing and drink driving), as well as for tracking changes over time in middle- and high-income countries. Additionally, the MOVING and NOURISHING policy benchmarking tools include sets of evidence-based, ambitious policy indicators for monitoring countries’ progress on physical activity and nutrition policies.20 To the authors’ best knowledge, however, no systematic or scoping review has comprehensively mapped and synthesised scientific publications describing the nature, characteristics and use of policy monitoring indexes related to major NCDs, which is the overarching aim of this scoping review. A preliminary search conducted in Medline and Embase in December 2025 identified no existing evidence synthesis addressing this topic. One scoping review21 did map quantitative tools for assessing the implementation of effective alcohol policies in general, covering pricing and taxation, marketing controls, physical availability and drink-driving measures, but did not focus on policy indexes specifically.21 Another recent scoping review of food policy evaluation methodologies concluded that more robust and standardised quantitative evaluation tools are needed to support evidence-based policymaking.22 The proposed review will examine policy monitoring indexes that target the four major NCDs, that is, cancer, diabetes, cardiovascular disease and chronic obstructive pulmonary disease, and/or their key behavioural risk factors, namely tobacco use, harmful alcohol consumption, unhealthy diets and physical inactivity. The review will assess if, and how, included indexes address social inequalities. Based on the review findings, we will identify gaps in existing monitoring approaches and propose areas for improvement. Stage 1: identifying the research questions The overall aim of this scoping review is to map and synthesise scientific publications that report on the nature, characteristics and use of policy monitoring indexes targeting the major NCDs and their common behavioural risk factors. The following research questions will be assessed in the included studies: What is the focus of each index (eg, which NCD and/or behavioural risk factors policies are being monitored)? What is the focus of each index (eg, which NCD and/or behavioural risk factors policies are being monitored)? How is the index constructed (eg, type of indicators, data sources, methods of aggregation and comparison, weighting and scoring systems)? How is the index constructed (eg, type of indicators, data sources, methods of aggregation and comparison, weighting and scoring systems)? What theoretical and/or empirical rationale underpins the methodological choices? What theoretical and/or empirical rationale underpins the methodological choices? Does the index account for social inequalities, and if so, in what way? Does the index account for social inequalities, and if so, in what way? For what purpose is the index developed and how is it used (eg, monitoring policy implementation, examining associations with health outcomes or assessing determinants of policy implementation)? For what purpose is the index developed and how is it used (eg, monitoring policy implementation, examining associations with health outcomes or assessing determinants of policy implementation)? Does the index capture policy enforcement vs lack of enforcement in relation to policy effectiveness, and how is this operationalised? Does the index capture policy enforcement vs lack of enforcement in relation to policy effectiveness, and how is this operationalised? Methods and analysis Protocol design, registration and reporting Given the purpose of the proposed study, a scoping review methodology was considered appropriate.23 As scoping reviews do not involve primary data collection or direct interaction with human participants, ethical approval is not required. This review will follow the Johanna Briggs Institute’s guidance for scoping reviews,24 which expands on and updates the methodological framework originally proposed by Arksey and O’Malley.25 In addition, the review reporting will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping reviews (PRISMA-ScR).26 The study commenced in mid-September 2025 and is expected to be completed by December 2026. This protocol is registered on Open Science Framework (https://osf.io/sntdz/overview). Eligibility criteria Studies meeting the following participant-concept-context criteria will be considered eligible for inclusion. Population Any composite index designed to monitor the implementation of NCD relevant policies. Concept Monitoring, that is, the systematic collection, analysis and use of data to assess the implementation of policies aimed at reducing the prevalence of major NCDs and/or related behavioural risk factors. Context National and/or supranational government-initiated policies, aimed at reducing the prevalence of major NCDs and/or their common behavioural risk factors, implemented within one or more policies within the WHO European region. Eligible policies may operate at primary, secondary or tertiary prevention levels, be universal, targeted or proportionally targeted and aim to influence behavioural change and/or structural change. Stage 2: identifying relevant studies Types of sources The proposed scoping review will include all types of empirical studies (observational cross-sectional studies, longitudinal panel studies, ecological studies, comparative political analyses, quasi-experimental studies and mixed-methods studies), in any language, that examine the nature, characteristics, and use of policy monitoring indexes targeting the four major NCDs and/or their common behavioural risk factors. Conceptual-only papers, commentaries, conference abstracts, editorials and letters will be excluded. We will search the grey literature, as time and resources permit. Relevant studies with an English abstract will be eligible for inclusion. Studies in other languages than English will be translated, if they are deemed eligible based on the English abstract. Studies targeting a broader region, for example, all WHO member states, will be included if data from the WHO European region can be extracted separately. We will include studies published from 2013 onwards, using the release of the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–202027 as a starting point. This action plan forms the basis for the WHO ‘Best buys’3, and was first endorsed in 2013, updated in 2017, and extended to 2030 following a World Health Assembly decision in 2019. 3 Search strategy The search strategy will aim to identify eligible observational, quasi-experimental and mixed-methods studies in any language and will follow established guidance for scoping reviews.24 25 It will be developed by a research librarian in collaboration with the lead author. A preliminary search of MEDLINE and Embase was conducted to locate relevant studies on the topic. The keywords appearing in the titles and abstracts of relevant articles, as well as the index terms used to describe them, informed the development of an initial search strategy for MEDLINE and Embase (online supplemental file 1). This draft search strategy, including both free text and indexed terms, will be tested and refined as needed, before being adapted to each database. The main search will be conducted from 1 January 2013 up to present in the following eight databases: MEDLINE, Embase, Cochrane CENTRAL, Global Health, PsycINFO, Web of Science Core Collection, Scopus and FRANCIS. To identify additional relevant studies that may not be captured through database searching, the CrossRef system will be used. Reference list of included studies, and relevant review articles, will also be screened for further eligible publications. In addition, grey literature sources will be searched, including websites of relevant organisations such as the WHO, the EU, the Organisation for Economic Co-operation and Development, the World Cancer Research Fund and the World Bank. Stage 3: study selection All identified citations will be imported to EndNote V.X9 (Clarivate Analytics, USA), and duplicates will be removed. After a pilot screening, two reviewers will independently screen titles and abstracts against the inclusion criteria using the screening software Covidence.28 Citations deemed potentially relevant will be retrieved in full text and assessed independently by two reviewers (from HBB, AH and GMF). Studies excluded after full text screening will be documented in a table of excluded studies, along with the reason(s) for exclusion. Any disagreements at any stage of the selection process will be resolved through discussion, or if necessary, using an arbitrator. The search results and the study selection process will be presented using the PRISMA-ScR flow diagram.26 Stage 4: charting the data Data from each included study will be extracted by two or more reviewers independently, using a tailored and piloted data extraction tool (online supplemental file 2). Extracted information will include general details about the included studies (eg, full citation, country/region), study aim, design and methods (data collection, analysis methods, theoretical and/or empirical rationale for methodological choices), information about the population, concept and context. Key findings relevant to the research questions will also be recorded. The data extraction tool will be modified as necessary throughout the process, and any changes will be documented in the final scoping review. Disagreements between reviewers will be resolved through discussion, or if needed, by arbitration. When required, authors of original studies will be contacted to obtain additional data relevant to the analysis. Stage 5: collating, summarising and reporting the results We will present the findings using a narrative summary, supported by tables that clearly show how the results align with the review’s aim and research questions. Where appropriate, we will use descriptive statistics and visual graphics (eg, pie charts and bubble plots) to illustrate key patterns in the data. The NCD Progress Monitor16 will serve as the overarching framework for mapping the results. This framework applies a set of eleven indicators to evaluate country compliance with the WHO ‘Best buys’ policies,3 which are themselves grounded in the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020.27 Patient and public involvement None. Ethics and dissemination Ethical approval will not be sought as scoping reviews do not involve primary data collection or direct interaction with human participants. The proposed scoping review is part of the Joint Action PreventNCD initiative, co-funded by the European Commission and involving 25 European countries, aiming to reduce Europe’s cancer and NCD burden through coordinated strategies targeting key health determinants.29 This review will contribute to the project’s objectives of advancing monitoring systems for NCDs and behavioural risk factors by providing an up-to-date overview of the existence, characteristics and use of policy monitoring indexes relevant to NCD prevention, and by identifying monitoring gaps that may require attention. We plan to disseminate findings at international conferences and to publish the full review in an international peer-reviewed journal. Supplementary material Acknowledgements We thank Astrid Merete Nøstberg, research librarian at NIPH for her assistance in developing the search strategy. The views expressed in this article are solely those of the authors and do not necessarily reflect the views of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor HaDEA can be held responsible for any use of the information contained herein. Footnotes Funding: This project (GA–101128023) is co-funded by the European Union. Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2026-118130). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. References Supplementary Materials